Response to Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013

Diabetes Care. 2023 Nov 1;46(11):e210-e211. doi: 10.2337/dci23-0050.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Letter
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Abatacept / therapeutic use
  • Diabetes Mellitus, Type 1* / drug therapy
  • Diabetes Mellitus, Type 2*
  • Double-Blind Method
  • Humans

Substances

  • Abatacept

Grants and funding